-
1
-
-
33645470121
-
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
-
Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949-953.
-
(2006)
Eur Heart J
, vol.27
, pp. 949-953
-
-
Heeringa, J.1
van der Kuip, D.A.2
Hofman, A.3
Kors, J.A.4
van Herpen, G.5
Stricker, B.H.6
Stijnen, T.7
Lip, G.Y.8
Witteman, J.C.9
-
2
-
-
84916925479
-
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
-
January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2014;130:e199-e267.
-
(2014)
Circulation
, vol.130
, pp. e199-e267
-
-
January, C.T.1
Wann, L.S.2
Alpert, J.S.3
Calkins, H.4
Cigarroa, J.E.5
Cleveland, J.C.6
Conti, J.B.7
Ellinor, P.T.8
Ezekowitz, M.D.9
Field, M.E.10
Murray, K.T.11
Sacco, R.L.12
Stevenson, W.G.13
Tchou, P.J.14
Tracy, C.M.15
Yancy, C.W.16
-
3
-
-
84896117299
-
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
-
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955-962.
-
(2014)
Lancet
, vol.383
, pp. 955-962
-
-
Ruff, C.T.1
Giugliano, R.P.2
Braunwald, E.3
Hoffman, E.B.4
Deenadayalu, N.5
Ezekowitz, M.D.6
Camm, A.J.7
Weitz, J.I.8
Lewis, B.S.9
Parkhomenko, A.10
Yamashita, T.11
Antman, E.M.12
-
4
-
-
20044388522
-
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: the losartan intervention for end point reduction in hypertension (LIFE) study
-
Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlof B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: the losartan intervention for end point reduction in hypertension (LIFE) study. J Am Coll Cardiol. 2005;45:705-711.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 705-711
-
-
Wachtell, K.1
Hornestam, B.2
Lehto, M.3
Slotwiner, D.J.4
Gerdts, E.5
Olsen, M.H.6
Aurup, P.7
Dahlof, B.8
Ibsen, H.9
Julius, S.10
Kjeldsen, S.E.11
Lindholm, L.H.12
Nieminen, M.S.13
Rokkedal, J.14
Devereux, R.B.15
-
5
-
-
54949116895
-
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis
-
863.e852.
-
Goto S, Bhatt DL, Rother J, Alberts M, Hill MD, Ikeda Y, Uchiyama S, D'Agostino R, Ohman EM, Liau CS, Hirsch AT, Mas JL, Wilson PW, Corbalan R, Aichner F, Steg PG; Investigators RR. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J. 2008;156:855-863, 863.e852.
-
(2008)
Am Heart J
, vol.156
, pp. 855-863
-
-
Goto, S.1
Bhatt, D.L.2
Rother, J.3
Alberts, M.4
Hill, M.D.5
Ikeda, Y.6
Uchiyama, S.7
D'Agostino, R.8
Ohman, E.M.9
Liau, C.S.10
Hirsch, A.T.11
Mas, J.L.12
Wilson, P.W.13
Corbalan, R.14
Aichner, F.15
Steg, P.G.16
-
6
-
-
77954312068
-
Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the reduction of atherothrombosis for continued health (REACH) registry
-
Winkel TA, Hoeks SE, Schouten O, Zeymer U, Limbourg T, Baumgartner I, Bhatt DL, Steg PG, Goto S, Rother J, Cacoub PP, Verhagen HJ, Bax JJ, Poldermans D. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the reduction of atherothrombosis for continued health (REACH) registry. Eur J Vasc Endovasc Surg. 2010;40:9-16.
-
(2010)
Eur J Vasc Endovasc Surg
, vol.40
, pp. 9-16
-
-
Winkel, T.A.1
Hoeks, S.E.2
Schouten, O.3
Zeymer, U.4
Limbourg, T.5
Baumgartner, I.6
Bhatt, D.L.7
Steg, P.G.8
Goto, S.9
Rother, J.10
Cacoub, P.P.11
Verhagen, H.J.12
Bax, J.J.13
Poldermans, D.14
-
7
-
-
80054936056
-
One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. Results from the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE)
-
Goto S, Ikeda Y, Shimada K, Uchiyama S, Origasa H, Kobayashi H; Investigators JT. One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. Results from the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE). Circ J. 2011;75:2598-2604.
-
(2011)
Circ J
, vol.75
, pp. 2598-2604
-
-
Goto, S.1
Ikeda, Y.2
Shimada, K.3
Uchiyama, S.4
Origasa, H.5
Kobayashi, H.6
-
8
-
-
84869501537
-
Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims
-
Hess PL, Greiner MA, Fonarow GC, Klaskala W, Mills RM, Setoguchi S, Al-Khatib SM, Hernandez AF, Curtis LH. Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims. Clin Cardiol. 2012;35:649-657.
-
(2012)
Clin Cardiol
, vol.35
, pp. 649-657
-
-
Hess, P.L.1
Greiner, M.A.2
Fonarow, G.C.3
Klaskala, W.4
Mills, R.M.5
Setoguchi, S.6
Al-Khatib, S.M.7
Hernandez, A.F.8
Curtis, L.H.9
-
9
-
-
84892426726
-
Atrial fibrillation and the risk of myocardial infarction
-
Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, Judd S, Howard VJ, Howard G, Herrington DM, Cushman M. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014;174:107-114.
-
(2014)
JAMA Intern Med
, vol.174
, pp. 107-114
-
-
Soliman, E.Z.1
Safford, M.M.2
Muntner, P.3
Khodneva, Y.4
Dawood, F.Z.5
Zakai, N.A.6
Thacker, E.L.7
Judd, S.8
Howard, V.J.9
Howard, G.10
Herrington, D.M.11
Cushman, M.12
-
10
-
-
84909974321
-
Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients
-
Andersson T, Magnuson A, Bryngelsson IL, Frobert O, Henriksson KM, Edvardsson N, Poci D. Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients. Int J Cardiol. 2014;177:91-99.
-
(2014)
Int J Cardiol
, vol.177
, pp. 91-99
-
-
Andersson, T.1
Magnuson, A.2
Bryngelsson, I.L.3
Frobert, O.4
Henriksson, K.M.5
Edvardsson, N.6
Poci, D.7
-
11
-
-
84930926059
-
2-VASc score of 0 or 1: a nationwide cohort study
-
2-VASc score of 0 or 1: a nationwide cohort study. Heart Rhythm. 2014;11:1941-1947.
-
(2014)
Heart Rhythm
, vol.11
, pp. 1941-1947
-
-
Chao, T.F.1
Huang, Y.C.2
Liu, C.J.3
Chen, S.J.4
Wang, K.L.5
Lin, Y.J.6
Chang, S.L.7
Lo, L.W.8
Hu, Y.F.9
Tuan, T.C.10
Chen, T.J.11
Hsieh, M.H.12
Lip, G.Y.13
Chen, S.A.14
-
12
-
-
84893729209
-
Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation
-
Senoo K, Suzuki S, Sagara K, Otsuka T, Matsuno S, Uejima T, Oikawa Y, Yajima J, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Lip GY, Yamashita T. Coronary artery diseases in Japanese patients with nonvalvular atrial fibrillation. J Cardiol. 2014;63:123-127.
-
(2014)
J Cardiol
, vol.63
, pp. 123-127
-
-
Senoo, K.1
Suzuki, S.2
Sagara, K.3
Otsuka, T.4
Matsuno, S.5
Uejima, T.6
Oikawa, Y.7
Yajima, J.8
Nagashima, K.9
Kirigaya, H.10
Sawada, H.11
Aizawa, T.12
Lip, G.Y.13
Yamashita, T.14
-
13
-
-
84901744289
-
Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the Veterans Health Administration
-
Shore S, Carey EP, Turakhia MP, Jackevicius CA, Cunningham F, Pilote L, Bradley SM, Maddox TM, Grunwald GK, Baron AE, Rumsfeld JS, Varosy PD, Schneider PM, Marzec LN, Ho PM. Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the Veterans Health Administration. Am Heart J. 2014;167:810-817.
-
(2014)
Am Heart J
, vol.167
, pp. 810-817
-
-
Shore, S.1
Carey, E.P.2
Turakhia, M.P.3
Jackevicius, C.A.4
Cunningham, F.5
Pilote, L.6
Bradley, S.M.7
Maddox, T.M.8
Grunwald, G.K.9
Baron, A.E.10
Rumsfeld, J.S.11
Varosy, P.D.12
Schneider, P.M.13
Marzec, L.N.14
Ho, P.M.15
-
14
-
-
84902549667
-
One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS Registry
-
Rubboli A, Schlitt A, Kiviniemi T, Biancari F, Karjalainen PP, Valencia J, Laine M, Kirchhof P, Niemela M, Vikman S, Lip GY, Airaksinen KE; Group AS. One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS Registry. Clin Cardiol. 2014;37:357-364.
-
(2014)
Clin Cardiol
, vol.37
, pp. 357-364
-
-
Rubboli, A.1
Schlitt, A.2
Kiviniemi, T.3
Biancari, F.4
Karjalainen, P.P.5
Valencia, J.6
Laine, M.7
Kirchhof, P.8
Niemela, M.9
Vikman, S.10
Lip, G.Y.11
Airaksinen, K.E.12
-
15
-
-
84902593669
-
Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study
-
Lamberts M, Lip GY, Ruwald MH, Hansen ML, Ozcan C, Kristensen SL, Kober L, Torp-Pedersen C, Gislason GH. Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study. J Am Coll Cardiol. 2014;63:2689-2698.
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 2689-2698
-
-
Lamberts, M.1
Lip, G.Y.2
Ruwald, M.H.3
Hansen, M.L.4
Ozcan, C.5
Kristensen, S.L.6
Kober, L.7
Torp-Pedersen, C.8
Gislason, G.H.9
-
16
-
-
84905189018
-
Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study
-
Martinez C, Katholing A, Freedman SB. Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study. Thromb Haemost. 2014;112:276-286.
-
(2014)
Thromb Haemost
, vol.112
, pp. 276-286
-
-
Martinez, C.1
Katholing, A.2
Freedman, S.B.3
-
17
-
-
84897883176
-
Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin
-
Larsen TB, Rasmussen LH, Gorst-Rasmussen A, Skjoth F, Rosenzweig M, Lane DA, Lip GY. Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin. Am J Med. 2014;127:329-336.e324.
-
(2014)
Am J Med
, vol.127
, pp. 329-336
-
-
Larsen, T.B.1
Rasmussen, L.H.2
Gorst-Rasmussen, A.3
Skjoth, F.4
Rosenzweig, M.5
Lane, D.A.6
Lip, G.Y.7
-
18
-
-
84893108089
-
Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke
-
Piccini JP, Hammill BG, Sinner MF, Hernandez AF, Walkey AJ, Benjamin EJ, Curtis LH, Heckbert SR. Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. Eur Heart J. 2014;35:250-256.
-
(2014)
Eur Heart J
, vol.35
, pp. 250-256
-
-
Piccini, J.P.1
Hammill, B.G.2
Sinner, M.F.3
Hernandez, A.F.4
Walkey, A.J.5
Benjamin, E.J.6
Curtis, L.H.7
Heckbert, S.R.8
-
19
-
-
84919860496
-
Atrial fibrillation and incident myocardial infarction in the elderly
-
O'Neal WT, Sangal K, Zhang ZM, Soliman EZ. Atrial fibrillation and incident myocardial infarction in the elderly. Clin Cardiol. 2014;37:750-755.
-
(2014)
Clin Cardiol
, vol.37
, pp. 750-755
-
-
O'Neal, W.T.1
Sangal, K.2
Zhang, Z.M.3
Soliman, E.Z.4
-
20
-
-
84899072952
-
Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study
-
Lamberts M, Gislason GH, Lip GY, Lassen JF, Olesen JB, Mikkelsen AP, Sorensen R, Kober L, Torp-Pedersen C, Hansen ML. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Circulation. 2014;129:1577-1585.
-
(2014)
Circulation
, vol.129
, pp. 1577-1585
-
-
Lamberts, M.1
Gislason, G.H.2
Lip, G.Y.3
Lassen, J.F.4
Olesen, J.B.5
Mikkelsen, A.P.6
Sorensen, R.7
Kober, L.8
Torp-Pedersen, C.9
Hansen, M.L.10
-
21
-
-
84930885254
-
Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors
-
Pastori D, Pignatelli P, Angelico F, Farcomeni A, Del Ben M, Vicario T, Bucci T, Raparelli V, Cangemi R, Tanzilli G, Lip GY, Violi F. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors. Chest. 2015;147:1644-1650.
-
(2015)
Chest
, vol.147
, pp. 1644-1650
-
-
Pastori, D.1
Pignatelli, P.2
Angelico, F.3
Farcomeni, A.4
Del Ben, M.5
Vicario, T.6
Bucci, T.7
Raparelli, V.8
Cangemi, R.9
Tanzilli, G.10
Lip, G.Y.11
Violi, F.12
-
22
-
-
84966687204
-
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
-
Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Kuhls S, van Eickels M, Turpie AG; Investigators X: XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation. Eur Heart J. 2015;37:1145-1153.
-
(2015)
Eur Heart J
, vol.37
, pp. 1145-1153
-
-
Camm, A.J.1
Amarenco, P.2
Haas, S.3
Hess, S.4
Kirchhof, P.5
Kuhls, S.6
van Eickels, M.7
Turpie, A.G.8
-
23
-
-
84935521079
-
Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study
-
Soliman EZ, Lopez F, O'Neal WT, Chen LY, Bengtson L, Zhang ZM, Loehr L, Cushman M, Alonso A. Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015;131:1843-1850.
-
(2015)
Circulation
, vol.131
, pp. 1843-1850
-
-
Soliman, E.Z.1
Lopez, F.2
O'Neal, W.T.3
Chen, L.Y.4
Bengtson, L.5
Zhang, Z.M.6
Loehr, L.7
Cushman, M.8
Alonso, A.9
-
24
-
-
84940056860
-
Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands
-
Vermond RA, Geelhoed B, Verweij N, Tieleman RG, Van der Harst P, Hillege HL, Van Gilst WH, Van Gelder IC, Rienstra M. Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands. J Am Coll Cardiol. 2015;66:1000-1007.
-
(2015)
J Am Coll Cardiol
, vol.66
, pp. 1000-1007
-
-
Vermond, R.A.1
Geelhoed, B.2
Verweij, N.3
Tieleman, R.G.4
Van der Harst, P.5
Hillege, H.L.6
Van Gilst, W.H.7
Van Gelder, I.C.8
Rienstra, M.9
-
25
-
-
68049137869
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
-
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.
-
(2009)
PLoS Med
, vol.6
-
-
Liberati, A.1
Altman, D.G.2
Tetzlaff, J.3
Mulrow, C.4
Gotzsche, P.C.5
Ioannidis, J.P.6
Clarke, M.7
Devereaux, P.J.8
Kleijnen, J.9
Moher, D.10
-
26
-
-
8244245263
-
Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (studio italiano fibrillazione atriale) Investigators
-
Morocutti C, Amabile G, Fattapposta F, Nicolosi A, Matteoli S, Trappolini M, Cataldo G, Milanesi G, Lavezzari M, Pamparana F, Coccheri S. Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (studio italiano fibrillazione atriale) Investigators. Stroke. 1997;28:1015-1021.
-
(1997)
Stroke
, vol.28
, pp. 1015-1021
-
-
Morocutti, C.1
Amabile, G.2
Fattapposta, F.3
Nicolosi, A.4
Matteoli, S.5
Trappolini, M.6
Cataldo, G.7
Milanesi, G.8
Lavezzari, M.9
Pamparana, F.10
Coccheri, S.11
-
27
-
-
0345414673
-
Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
-
Olsson SB; Executive Steering Committee of the SIIII. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial. Lancet. 2003;362:1691-1698.
-
(2003)
Lancet
, vol.362
, pp. 1691-1698
-
-
Olsson, S.B.1
-
28
-
-
33744945247
-
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial
-
Investigators AWGotA, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903-1912.
-
(2006)
Lancet
, vol.367
, pp. 1903-1912
-
-
Connolly, S.1
Pogue, J.2
Hart, R.3
Pfeffer, M.4
Hohnloser, S.5
Chrolavicius, S.6
Pfeffer, M.7
Hohnloser, S.8
Yusuf, S.9
-
29
-
-
42349110494
-
Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial
-
Hart RG, Bhatt DL, Hacke W, Fox KA, Hankey GJ, Berger PB, Hu T, Topol EJ; Investigators C. Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial. Cerebrovasc Dis. 2008;25:344-347.
-
(2008)
Cerebrovasc Dis
, vol.25
, pp. 344-347
-
-
Hart, R.G.1
Bhatt, D.L.2
Hacke, W.3
Fox, K.A.4
Hankey, G.J.5
Berger, P.B.6
Hu, T.7
Topol, E.J.8
-
30
-
-
65649145705
-
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
-
Investigators A, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360:2066-2078.
-
(2009)
N Engl J Med
, vol.360
, pp. 2066-2078
-
-
Connolly, S.J.1
Pogue, J.2
Hart, R.G.3
Hohnloser, S.H.4
Pfeffer, M.5
Chrolavicius, S.6
Yusuf, S.7
-
31
-
-
74049143913
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; Committee R-LS, Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151.
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
Eikelboom, J.4
Oldgren, J.5
Parekh, A.6
Pogue, J.7
Reilly, P.A.8
Themeles, E.9
Varrone, J.10
Wang, S.11
Alings, M.12
Xavier, D.13
Zhu, J.14
Diaz, R.15
Lewis, B.S.16
Darius, H.17
Diener, H.C.18
Joyner, C.D.19
Wallentin, L.20
more..
-
32
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; Committees A, Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-992.
-
(2011)
N Engl J Med
, vol.365
, pp. 981-992
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
Lopes, R.D.4
Hylek, E.M.5
Hanna, M.6
Al-Khalidi, H.R.7
Ansell, J.8
Atar, D.9
Avezum, A.10
Bahit, M.C.11
Diaz, R.12
Easton, J.D.13
Ezekowitz, J.A.14
Flaker, G.15
Garcia, D.16
Geraldes, M.17
Gersh, B.J.18
Golitsyn, S.19
Goto, S.20
Hermosillo, A.G.21
Hohnloser, S.H.22
Horowitz, J.23
Mohan, P.24
Jansky, P.25
Lewis, B.S.26
Lopez-Sendon, J.L.27
Pais, P.28
Parkhomenko, A.29
Verheugt, F.W.30
Zhu, J.31
Wallentin, L.32
more..
-
33
-
-
79952301326
-
Apixaban in patients with atrial fibrillation
-
Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Munawar M, O'Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S; Committee AS, Investigators. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364:806-817.
-
(2011)
N Engl J Med
, vol.364
, pp. 806-817
-
-
Connolly, S.J.1
Eikelboom, J.2
Joyner, C.3
Diener, H.C.4
Hart, R.5
Golitsyn, S.6
Flaker, G.7
Avezum, A.8
Hohnloser, S.H.9
Diaz, R.10
Talajic, M.11
Zhu, J.12
Pais, P.13
Budaj, A.14
Parkhomenko, A.15
Jansky, P.16
Commerford, P.17
Tan, R.S.18
Sim, K.H.19
Lewis, B.S.20
Van Mieghem, W.21
Lip, G.Y.22
Kim, J.H.23
Lanas-Zanetti, F.24
Gonzalez-Hermosillo, A.25
Dans, A.L.26
Munawar, M.27
O'Donnell, M.28
Lawrence, J.29
Lewis, G.30
Afzal, R.31
Yusuf, S.32
more..
-
34
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; Investigators RA. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891.
-
(2011)
N Engl J Med
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
Pan, G.4
Singer, D.E.5
Hacke, W.6
Breithardt, G.7
Halperin, J.L.8
Hankey, G.J.9
Piccini, J.P.10
Becker, R.C.11
Nessel, C.C.12
Paolini, J.F.13
Berkowitz, S.D.14
Fox, K.A.15
Califf, R.M.16
-
35
-
-
84888362796
-
Edoxaban versus warfarin in patients with atrial fibrillation
-
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; Investigators EA-T. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369:2093-2104.
-
(2013)
N Engl J Med
, vol.369
, pp. 2093-2104
-
-
Giugliano, R.P.1
Ruff, C.T.2
Braunwald, E.3
Murphy, S.A.4
Wiviott, S.D.5
Halperin, J.L.6
Waldo, A.L.7
Ezekowitz, M.D.8
Weitz, J.I.9
Spinar, J.10
Ruzyllo, W.11
Ruda, M.12
Koretsune, Y.13
Betcher, J.14
Shi, M.15
Grip, L.T.16
Patel, S.P.17
Patel, I.18
Hanyok, J.J.19
Mercuri, M.20
Antman, E.M.21
more..
-
36
-
-
84893046356
-
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial
-
Mahaffey KW, Stevens SR, White HD, Nessel CC, Goodman SG, Piccini JP, Patel MR, Becker RC, Halperin JL, Hacke W, Singer DE, Hankey GJ, Califf RM, Fox KA, Breithardt G; Investigators RA. Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial. Eur Heart J. 2014;35:233-241.
-
(2014)
Eur Heart J
, vol.35
, pp. 233-241
-
-
Mahaffey, K.W.1
Stevens, S.R.2
White, H.D.3
Nessel, C.C.4
Goodman, S.G.5
Piccini, J.P.6
Patel, M.R.7
Becker, R.C.8
Halperin, J.L.9
Hacke, W.10
Singer, D.E.11
Hankey, G.J.12
Califf, R.M.13
Fox, K.A.14
Breithardt, G.15
-
37
-
-
84899629696
-
'Real-world' antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey
-
Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP. 'Real-world' antithrombotic treatment in atrial fibrillation: the EORP-AF pilot survey. Am J Med. 2014;127:519-529.e511.
-
(2014)
Am J Med
, vol.127
, pp. 519-529
-
-
Lip, G.Y.1
Laroche, C.2
Dan, G.A.3
Santini, M.4
Kalarus, Z.5
Rasmussen, L.H.6
Ioachim, P.M.7
Tica, O.8
Boriani, G.9
Cimaglia, P.10
Diemberger, I.11
Hellum, C.F.12
Mortensen, B.13
Maggioni, A.P.14
-
38
-
-
84891353605
-
Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: primary results of the Prevention of Thromboemolic Events-European Registry in Atrial Fibrillation (PREFER in AF)
-
Kirchhof P, Ammentorp B, Darius H, De Caterina R, Le Heuzey JY, Schilling RJ, Schmitt J, Zamorano JL. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: primary results of the Prevention of Thromboemolic Events-European Registry in Atrial Fibrillation (PREFER in AF). Europace. 2014;16:6-14.
-
(2014)
Europace
, vol.16
, pp. 6-14
-
-
Kirchhof, P.1
Ammentorp, B.2
Darius, H.3
De Caterina, R.4
Le Heuzey, J.Y.5
Schilling, R.J.6
Schmitt, J.7
Zamorano, J.L.8
-
40
-
-
84941952876
-
Inflammation and hemostasis in atrial fibrillation and coronary heart disease: the reasons for geographic and racial differences in stroke study
-
O'Neal WT, Soliman EZ, Howard G, Howard VJ, Safford MM, Cushman M, Zakai NA. Inflammation and hemostasis in atrial fibrillation and coronary heart disease: the reasons for geographic and racial differences in stroke study. Atherosclerosis. 2015;243:192-197.
-
(2015)
Atherosclerosis
, vol.243
, pp. 192-197
-
-
O'Neal, W.T.1
Soliman, E.Z.2
Howard, G.3
Howard, V.J.4
Safford, M.M.5
Cushman, M.6
Zakai, N.A.7
-
41
-
-
0030754003
-
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease
-
Davi G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci GG, Ciabattoni G, Patrono C. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation. 1997;96:69-75.
-
(1997)
Circulation
, vol.96
, pp. 69-75
-
-
Davi, G.1
Gresele, P.2
Violi, F.3
Basili, S.4
Catalano, M.5
Giammarresi, C.6
Volpato, R.7
Nenci, G.G.8
Ciabattoni, G.9
Patrono, C.10
-
42
-
-
0022764019
-
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation
-
Catella F, Healy D, Lawson JA, FitzGerald GA. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proc Natl Acad Sci USA. 1986;83:5861-5865.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 5861-5865
-
-
Catella, F.1
Healy, D.2
Lawson, J.A.3
FitzGerald, G.A.4
-
43
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
44
-
-
41949108677
-
Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation
-
Duygu H, Barisik V, Kurt H, Turk U, Ercan E, Kose S. Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation. Europace. 2008;10:210-214.
-
(2008)
Europace
, vol.10
, pp. 210-214
-
-
Duygu, H.1
Barisik, V.2
Kurt, H.3
Turk, U.4
Ercan, E.5
Kose, S.6
-
45
-
-
36348929899
-
Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation
-
Ferro D, Loffredo L, Polimeni L, Fimognari F, Villari P, Pignatelli P, Fuster V, Violi F. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation. Arterioscler Thromb Vasc Biol. 2007;27:2763-2768.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 2763-2768
-
-
Ferro, D.1
Loffredo, L.2
Polimeni, L.3
Fimognari, F.4
Villari, P.5
Pignatelli, P.6
Fuster, V.7
Violi, F.8
-
46
-
-
84925321791
-
Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation
-
Pignatelli P, Pastori D, Carnevale R, Farcomeni A, Cangemi R, Nocella C, Bartimoccia S, Vicario T, Saliola M, Lip GY, Violi F. Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation. Thromb Haemost. 2015;113:617-624.
-
(2015)
Thromb Haemost
, vol.113
, pp. 617-624
-
-
Pignatelli, P.1
Pastori, D.2
Carnevale, R.3
Farcomeni, A.4
Cangemi, R.5
Nocella, C.6
Bartimoccia, S.7
Vicario, T.8
Saliola, M.9
Lip, G.Y.10
Violi, F.11
-
47
-
-
0041922325
-
The isoprostanes: unique products of arachidonic acid oxidation-a review
-
Fam SS, Morrow JD. The isoprostanes: unique products of arachidonic acid oxidation-a review. Curr Med Chem. 2003;10:1723-1740.
-
(2003)
Curr Med Chem
, vol.10
, pp. 1723-1740
-
-
Fam, S.S.1
Morrow, J.D.2
-
48
-
-
84901008746
-
Supply/demand type 2 myocardial infarction: should we be paying more attention?
-
Sandoval Y, Smith SW, Thordsen SE, Apple FS. Supply/demand type 2 myocardial infarction: should we be paying more attention? J Am Coll Cardiol. 2014;63:2079-2087.
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 2079-2087
-
-
Sandoval, Y.1
Smith, S.W.2
Thordsen, S.E.3
Apple, F.S.4
-
49
-
-
84938631468
-
Embolic myocardial infarction as a consequence of atrial fibrillation: a prevailing disease of the future
-
Kolodgie FD, Virmani R, Finn AV, Romero ME. Embolic myocardial infarction as a consequence of atrial fibrillation: a prevailing disease of the future. Circulation. 2015;132:223-226.
-
(2015)
Circulation
, vol.132
, pp. 223-226
-
-
Kolodgie, F.D.1
Virmani, R.2
Finn, A.V.3
Romero, M.E.4
-
50
-
-
84938614159
-
Prevalence, clinical features, and prognosis of acute myocardial infarction attributable to coronary artery embolism
-
Shibata T, Kawakami S, Noguchi T, Tanaka T, Asaumi Y, Kanaya T, Nagai T, Nakao K, Fujino M, Nagatsuka K, Ishibashi-Ueda H, Nishimura K, Miyamoto Y, Kusano K, Anzai T, Goto Y, Ogawa H, Yasuda S. Prevalence, clinical features, and prognosis of acute myocardial infarction attributable to coronary artery embolism. Circulation. 2015;132:241-250.
-
(2015)
Circulation
, vol.132
, pp. 241-250
-
-
Shibata, T.1
Kawakami, S.2
Noguchi, T.3
Tanaka, T.4
Asaumi, Y.5
Kanaya, T.6
Nagai, T.7
Nakao, K.8
Fujino, M.9
Nagatsuka, K.10
Ishibashi-Ueda, H.11
Nishimura, K.12
Miyamoto, Y.13
Kusano, K.14
Anzai, T.15
Goto, Y.16
Ogawa, H.17
Yasuda, S.18
-
51
-
-
0037034968
-
Noninvasive surrogate markers of atherosclerosis
-
discussion 43C-44C.
-
Feinstein SB, Voci P, Pizzuto F. Noninvasive surrogate markers of atherosclerosis. Am J Cardiol. 2002;89:31C-43C; discussion 43C-44C.
-
(2002)
Am J Cardiol
, vol.89
, pp. 31C-43C
-
-
Feinstein, S.B.1
Voci, P.2
Pizzuto, F.3
-
52
-
-
84920641606
-
Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients
-
Perri L, Pastori D, Pignatelli P, Violi F, Loffredo L. Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients. Int J Cardiol. 2015;179:139-143.
-
(2015)
Int J Cardiol
, vol.179
, pp. 139-143
-
-
Perri, L.1
Pastori, D.2
Pignatelli, P.3
Violi, F.4
Loffredo, L.5
-
53
-
-
84964732950
-
Ankle-brachial index and cardiovascular events in atrial fibrillation. The ARAPACIS Study
-
Violi F, Davi G, Proietti M, Pastori D, Hiatt WR, Corazza GR, Perticone F, Pignatelli P, Farcomeni A, Vestri AR, Lip GY, Basili S; Investigators AS. Ankle-brachial index and cardiovascular events in atrial fibrillation. The ARAPACIS Study. Thromb Haemost. 2016;115:856-863.
-
(2016)
Thromb Haemost
, vol.115
, pp. 856-863
-
-
Violi, F.1
Davi, G.2
Proietti, M.3
Pastori, D.4
Hiatt, W.R.5
Corazza, G.R.6
Perticone, F.7
Pignatelli, P.8
Farcomeni, A.9
Vestri, A.R.10
Lip, G.Y.11
Basili, S.12
-
54
-
-
84862119222
-
European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
-
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; European Association for Cardiovascular P, Rehabilitation, Guidelines ESCCfP, European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635-1701.
-
(2012)
Eur Heart J
, vol.33
, pp. 1635-1701
-
-
Perk, J.1
De Backer, G.2
Gohlke, H.3
Graham, I.4
Reiner, Z.5
Verschuren, M.6
Albus, C.7
Benlian, P.8
Boysen, G.9
Cifkova, R.10
Deaton, C.11
Ebrahim, S.12
Fisher, M.13
Germano, G.14
Hobbs, R.15
Hoes, A.16
Karadeniz, S.17
Mezzani, A.18
Prescott, E.19
Ryden, L.20
Scherer, M.21
Syvanne, M.22
Scholteop Reimer, W.J.23
Vrints, C.24
Wood, D.25
Zamorano, J.L.26
Zannad, F.27
more..
-
55
-
-
77649198148
-
Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial
-
Fowkes FG, Price JF, Stewart MC, Butcher I, Leng GC, Pell AC, Sandercock PA, Fox KA, Lowe GD, Murray GD; Aspirin for Asymptomatic Atherosclerosis T. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA. 2010;303:841-848.
-
(2010)
JAMA
, vol.303
, pp. 841-848
-
-
Fowkes, F.G.1
Price, J.F.2
Stewart, M.C.3
Butcher, I.4
Leng, G.C.5
Pell, A.C.6
Sandercock, P.A.7
Fox, K.A.8
Lowe, G.D.9
Murray, G.D.10
-
56
-
-
84859040554
-
Comparison of ankle-brachial index in patients with and without atrial fibrillation
-
Masanauskiene E, Naudziunas A. Comparison of ankle-brachial index in patients with and without atrial fibrillation. Medicina. 2011;47:641-645.
-
(2011)
Medicina
, vol.47
, pp. 641-645
-
-
Masanauskiene, E.1
Naudziunas, A.2
-
57
-
-
84930212512
-
Relationship between low ankle-brachial index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study
-
Violi F, Pastori D, Perticone F, Hiatt WR, Sciacqua A, Basili S, Proietti M, Corazza GR, Lip GY, Pignatelli P; Group AS. Relationship between low ankle-brachial index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study. BMJ Open. 2015;5:e008026.
-
(2015)
BMJ Open
, vol.5
-
-
Violi, F.1
Pastori, D.2
Perticone, F.3
Hiatt, W.R.4
Sciacqua, A.5
Basili, S.6
Proietti, M.7
Corazza, G.R.8
Lip, G.Y.9
Pignatelli, P.10
-
58
-
-
51549102475
-
Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients
-
Muiesan ML, Salvetti M, Paini A, Monteduro C, Galbassini G, Poisa P, Porteri E, Agabiti-Rosei C, Paderno V, Belotti E, Rizzoni D, Castellano M, Agabiti-Rosei E. Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients. J Hypertens. 2008;26:1612-1618.
-
(2008)
J Hypertens
, vol.26
, pp. 1612-1618
-
-
Muiesan, M.L.1
Salvetti, M.2
Paini, A.3
Monteduro, C.4
Galbassini, G.5
Poisa, P.6
Porteri, E.7
Agabiti-Rosei, C.8
Paderno, V.9
Belotti, E.10
Rizzoni, D.11
Castellano, M.12
Agabiti-Rosei, E.13
-
59
-
-
12844270491
-
Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure
-
Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, Yasskiy A. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation. 2005;111:310-314.
-
(2005)
Circulation
, vol.111
, pp. 310-314
-
-
Katz, S.D.1
Hryniewicz, K.2
Hriljac, I.3
Balidemaj, K.4
Dimayuga, C.5
Hudaihed, A.6
Yasskiy, A.7
-
60
-
-
33947393160
-
Comparative predictive and diagnostic value of flow-mediated vasodilation in the brachial artery and intima media thickness of the carotid artery for assessment of coronary artery disease severity
-
Matsushima Y, Takase B, Uehata A, Kawano H, Yano K, Ohsuzu F, Ishihara M, Kurita A. Comparative predictive and diagnostic value of flow-mediated vasodilation in the brachial artery and intima media thickness of the carotid artery for assessment of coronary artery disease severity. Int J Cardiol. 2007;117:165-172.
-
(2007)
Int J Cardiol
, vol.117
, pp. 165-172
-
-
Matsushima, Y.1
Takase, B.2
Uehata, A.3
Kawano, H.4
Yano, K.5
Ohsuzu, F.6
Ishihara, M.7
Kurita, A.8
-
61
-
-
77957933610
-
Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis
-
Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J Cardiovasc Imaging. 2010;26:631-640.
-
(2010)
Int J Cardiovasc Imaging
, vol.26
, pp. 631-640
-
-
Inaba, Y.1
Chen, J.A.2
Bergmann, S.R.3
-
62
-
-
84920641606
-
Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients
-
Perri L, Pastori D, Pignatelli P, Violi F, Loffredo L. Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients. Int J Cardiol. 2014;179C:139-143.
-
(2014)
Int J Cardiol
, vol.179C
, pp. 139-143
-
-
Perri, L.1
Pastori, D.2
Pignatelli, P.3
Violi, F.4
Loffredo, L.5
-
64
-
-
0037116641
-
Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey
-
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
-
(2002)
JAMA
, vol.287
, pp. 356-359
-
-
Ford, E.S.1
Giles, W.H.2
Dietz, W.H.3
-
65
-
-
77957198071
-
The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis
-
Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113-1132.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 1113-1132
-
-
Mottillo, S.1
Filion, K.B.2
Genest, J.3
Joseph, L.4
Pilote, L.5
Poirier, P.6
Rinfret, S.7
Schiffrin, E.L.8
Eisenberg, M.J.9
-
66
-
-
40549117855
-
Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study
-
Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, Aizawa Y. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation. 2008;117:1255-1260.
-
(2008)
Circulation
, vol.117
, pp. 1255-1260
-
-
Watanabe, H.1
Tanabe, N.2
Watanabe, T.3
Darbar, D.4
Roden, D.M.5
Sasaki, S.6
Aizawa, Y.7
-
67
-
-
58149469403
-
Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome
-
Chang SL, Tuan TC, Tai CT, Lin YJ, Lo LW, Hu YF, Tsao HM, Chang CJ, Tsai WC, Chen SA. Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome. Am J Cardiol. 2009;103:67-72.
-
(2009)
Am J Cardiol
, vol.103
, pp. 67-72
-
-
Chang, S.L.1
Tuan, T.C.2
Tai, C.T.3
Lin, Y.J.4
Lo, L.W.5
Hu, Y.F.6
Tsao, H.M.7
Chang, C.J.8
Tsai, W.C.9
Chen, S.A.10
-
68
-
-
84959886164
-
Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score
-
Pastori D, Farcomeni A, Poli D, Antonucci E, Angelico F, Del Ben M, Cangemi R, Tanzilli G, Lip GY, Pignatelli P, Violi F. Cardiovascular risk stratification in patients with non-valvular atrial fibrillation: the 2MACE score. Intern Emerg Med. 2016;11:199-204.
-
(2016)
Intern Emerg Med
, vol.11
, pp. 199-204
-
-
Pastori, D.1
Farcomeni, A.2
Poli, D.3
Antonucci, E.4
Angelico, F.5
Del Ben, M.6
Cangemi, R.7
Tanzilli, G.8
Lip, G.Y.9
Pignatelli, P.10
Violi, F.11
-
69
-
-
84946720807
-
New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction
-
Stamboul K, Fauchier L, Gudjoncik A, Buffet P, Garnier F, Lorgis L, Beer JC, Touzery C, Cottin Y. New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction. Arch Cardiovasc Dis. 2015;108:598-605.
-
(2015)
Arch Cardiovasc Dis
, vol.108
, pp. 598-605
-
-
Stamboul, K.1
Fauchier, L.2
Gudjoncik, A.3
Buffet, P.4
Garnier, F.5
Lorgis, L.6
Beer, J.C.7
Touzery, C.8
Cottin, Y.9
-
70
-
-
0028082271
-
Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group
-
Cohen M, Adams PC, Parry G, Xiong J, Chamberlain D, Wieczorek I, Fox KA, Chesebro JH, Strain J, Keller C. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation. 1994;89:81-88.
-
(1994)
Circulation
, vol.89
, pp. 81-88
-
-
Cohen, M.1
Adams, P.C.2
Parry, G.3
Xiong, J.4
Chamberlain, D.5
Wieczorek, I.6
Fox, K.A.7
Chesebro, J.H.8
Strain, J.9
Keller, C.10
-
71
-
-
84943514263
-
Inadequate anticoagulation by vitamin K antagonists is associated with major adverse cardiovascular events in patients with atrial fibrillation
-
Pastori D, Pignatelli P, Saliola M, Carnevale R, Vicario T, Del Ben M, Cangemi R, Barilla F, Lip GY, Violi F. Inadequate anticoagulation by vitamin K antagonists is associated with major adverse cardiovascular events in patients with atrial fibrillation. Int J Cardiol. 2015;201:513-516.
-
(2015)
Int J Cardiol
, vol.201
, pp. 513-516
-
-
Pastori, D.1
Pignatelli, P.2
Saliola, M.3
Carnevale, R.4
Vicario, T.5
Del Ben, M.6
Cangemi, R.7
Barilla, F.8
Lip, G.Y.9
Violi, F.10
-
72
-
-
84862907587
-
Rivaroxaban in patients with a recent acute coronary syndrome
-
Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; Investigators AAT. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012;366:9-19.
-
(2012)
N Engl J Med
, vol.366
, pp. 9-19
-
-
Mega, J.L.1
Braunwald, E.2
Wiviott, S.D.3
Bassand, J.P.4
Bhatt, D.L.5
Bode, C.6
Burton, P.7
Cohen, M.8
Cook-Bruns, N.9
Fox, K.A.10
Goto, S.11
Murphy, S.A.12
Plotnikov, A.N.13
Schneider, D.14
Sun, X.15
Verheugt, F.W.16
Gibson, C.M.17
-
73
-
-
84874812584
-
Statins for the primary prevention of cardiovascular disease
-
Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD004816.
-
(2013)
Cochrane Database Syst Rev
, vol.1
-
-
Taylor, F.1
Huffman, M.D.2
Macedo, A.F.3
Moore, T.H.4
Burke, M.5
Davey Smith, G.6
Ward, K.7
Ebrahim, S.8
-
74
-
-
84941736373
-
Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation
-
Pastori D, Pignatelli P, Farcomeni A, Cangemi R, Hiatt WR, Bartimoccia S, Nocella C, Vicario T, Bucci T, Carnevale R, Lip GY, Violi F. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation. Am Heart J. 2015;170:490-497.e491.
-
(2015)
Am Heart J
, vol.170
, pp. 490-497
-
-
Pastori, D.1
Pignatelli, P.2
Farcomeni, A.3
Cangemi, R.4
Hiatt, W.R.5
Bartimoccia, S.6
Nocella, C.7
Vicario, T.8
Bucci, T.9
Carnevale, R.10
Lip, G.Y.11
Violi, F.12
-
75
-
-
84939613810
-
Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists
-
Pignatelli P, Pastori D, Vicario T, Bucci T, Del Ben M, Russo R, Tanzilli A, Nardoni ML, Bartimoccia S, Nocella C, Ferro D, Saliola M, Cangemi R, Lip GY, Violi F. Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists. Europace. 2015;17:1223-1228.
-
(2015)
Europace
, vol.17
, pp. 1223-1228
-
-
Pignatelli, P.1
Pastori, D.2
Vicario, T.3
Bucci, T.4
Del Ben, M.5
Russo, R.6
Tanzilli, A.7
Nardoni, M.L.8
Bartimoccia, S.9
Nocella, C.10
Ferro, D.11
Saliola, M.12
Cangemi, R.13
Lip, G.Y.14
Violi, F.15
-
76
-
-
84940762898
-
Does Mediterranean diet reduce cardiovascular events and oxidative stress in atrial fibrillation?
-
Pastori D, Carnevale R, Bartimoccia S, Nocella C, Tanzilli G, Cangemi R, Vicario T, Catena M, Violi F, Pignatelli P. Does Mediterranean diet reduce cardiovascular events and oxidative stress in atrial fibrillation? Antioxid Redox Signal. 2015;23:682-687.
-
(2015)
Antioxid Redox Signal
, vol.23
, pp. 682-687
-
-
Pastori, D.1
Carnevale, R.2
Bartimoccia, S.3
Nocella, C.4
Tanzilli, G.5
Cangemi, R.6
Vicario, T.7
Catena, M.8
Violi, F.9
Pignatelli, P.10
-
77
-
-
0033851515
-
Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction
-
Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 959-969
-
-
Alpert, J.S.1
Thygesen, K.2
Antman, E.3
Bassand, J.P.4
-
78
-
-
84867362492
-
Third universal definition of myocardial infarction
-
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESCAAHAWHFTFfUDoMI, Authors/Task Force Members C, Thygesen K, Alpert JS, White HD; Biomarker S, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA; Subcommittee ECG, Chaitman BR, Clemmensen PM, Johanson P, Hod H; Imaging S, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ; Classification S, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW; Intervention S, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J; Trials, Registries S, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML; Trials, Registries S, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G; Trials, Registries S, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D; Trials, Registries S, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; Guidelines ESCCfP, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document R, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581-1598.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 1581-1598
-
-
Thygesen, K.1
Alpert, J.S.2
Jaffe, A.S.3
Simoons, M.L.4
Chaitman, B.R.5
White, H.D.6
Thygesen, K.7
Alpert, J.S.8
White, H.D.9
Jaffe, A.S.10
Katus, H.A.11
Apple, F.S.12
Lindahl, B.13
Morrow, D.A.14
Chaitman, B.R.15
Clemmensen, P.M.16
Johanson, P.17
Hod, H.18
Underwood, R.19
Bax, J.J.20
Bonow, J.J.21
Pinto, F.22
Gibbons, R.J.23
Fox, K.A.24
Atar, D.25
Newby, L.K.26
Galvani, M.27
Hamm, C.W.28
Uretsky, B.F.29
Steg, P.G.30
Wijns, W.31
Bassand, J.P.32
Menasche, P.33
Ravkilde, J.34
Ohman, E.M.35
Antman, E.M.36
Wallentin, L.C.37
Armstrong, P.W.38
Simoons, M.L.39
Januzzi, J.L.40
Nieminen, M.S.41
Gheorghiade, M.42
Filippatos, G.43
Luepker, R.V.44
Fortmann, S.P.45
Rosamond, W.D.46
Levy, D.47
Wood, D.48
Smith, S.C.49
Hu, D.50
Lopez-Sendon, J.L.51
Robertson, R.M.52
Weaver, D.53
Tendera, M.54
Bove, A.A.55
Parkhomenko, A.N.56
Vasilieva, E.J.57
Mendis, S.58
Bax, J.J.59
Baumgartner, H.60
Ceconi, C.61
Dean, V.62
Deaton, C.63
Fagard, R.64
Funck-Brentano, C.65
Hasdai, D.66
Hoes, A.67
Kirchhof, P.68
Knuuti, J.69
Kolh, P.70
McDonagh, T.71
more..
|